Hepatitis C Drugs Market Global Forecast By Distribution Channels – Renub Research

Hepatitis C is a viral infection that causes severe damage to the human body; it is an infection caused by a virus that damages the liver, which leads to inflammation. It spread through contaminated blood. The prevalence of hepatitis C infection among the global populace is escalating. This is mainly caused by sharing needles, unsterilized medical equipment, and a blood transfusion from infected mothers to newborn babies. As per Renub Research Analysis, the Global Hepatitis C drugs Market would be US$ 5.9 Billion by 2025.

In recent years, several drugs have been launched due to the high prevalence of Hepatitis C across the globe. Hepatitis C drug market is always developing, and competition is between new launches of fixed-dose combination led to a change in revenue of companies. The newly launched drug by AbbiVie i.e., Mavyret, has led to a downfall in the revenue of one of the market leader i.e. Gilead’s. Mavyret has several advantages compared to other drugs such as its treatment course is shorter, and it is much cheaper. Harvoni drugs are popular in India, and it’s easier affordable among the public.

Oral injections and dosages are required weekly in Hepatitis C; at the same time, its side effects can lead to permanent damage of other organs of patients. Around the globe, many clinical trials, as well as numerous successful drug clearances, give traction to this market. Apart from that, the rising number of regulatory approvals will further boost the market during the forecast time frame.

Hepatitis C drugs have witnessed numerous drug approvals likewise, in the year 2019, USFDA approves Mavyret for the treatment of pediatric hepatitis patients. For the treatment of all genotypes of Hepatitis C, Mavyret was the first treatment.

In the North American region, rising adoption of hepatitis C drugs will favor the surging of the market. The market share of Asia – Pacific’s and Latin American regions will grow during the forecast period.

Renub Research report titled “Hepatitis C Drugs Market Global Forecast By Drugs (Mavyret, Viekira Pak, Harvoni, Epclusa, Sovaldi, Vosevi, Zepatier, Others), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy), Regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Company Analysis (Abbvie, Gilead Sciences, Merck ,Bristol-Myers Squibb, Others)” provides a complete analysis Hepatitis C market globally.

Request a free Brochure copy of the report: https://www.renub.com/request-sample-page.php?gturl=hepatitis-c-market-and-forecast-hepatitis-c-pipeline-drugs-sales-and-forecast-clinical-trials-global-466-p.php

Mavyret is the leading drug in the global hepatitis C market

Complete analysis of 7 drugs Mavyret, Viekira Pak, Harvoni, Epclusa, Sovaldi, Vosevi, Zepatier, Others are given in the report. Mavyret is the leading drug in the global hepatitis C market.

Distribution Channel is dominated by Hospital Pharmacies in the Global Hepatitis C Drugs Market

Distribution channels like Hospital Pharmacies, Retail Pharmacies & Online Pharmacy are covered in this research report. Hospital Pharmacies is the leading distribution channel in the global hepatitis C drug market.

North America and Europe are the top two leading regions in the Global Hepatitis C Drugs Market

The report studies the hepatitis C drug market of the following regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are the top two leading regions in the global hepatitis C drug market.

All the companies have been studied from two points

• Recent Developments
• Sales Analysis

By Company – Global Hepatitis C Drugs Market

• Abbvie
• Gilead Sciences, Inc.
• Merck & Co. Inc.
• Bristol-Myers Squibb
• Others

By Regions – Global Hepatitis C Drugs Market

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

By Drugs – Global Hepatitis C Drugs Market

• Mavyret
• Viekira Pak
• Harvoni
• Epclusa
• Sovaldi
• Vosevi
• Zepatier
• Others

By Distribution Channels – Global Hepatitis C Drugs Market

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacy

About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us

Renub Research
Phone: +1-678-302-0700
Email: info@renub.com
Website: www.renub.com
Follow us on LinkedIn: www.linkedin.com/company/renub-research

China Cancer Drug Market will reach US$ 30.5 Billion by 2025 – Renub Research

China Cancer Drugs Market, by Drugs, Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy, Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market.

According to Renub Research, China Cancer Drug Market will reach US$ 30.5 Billion by the end of the year 2025. The core factors that will support the market growth are; rising healthcare infrastructure, increasing cancer testing center, increasing prevalence of cancer disease in China, the launch of various effective cancer drugs in the Chinese market.

China Cancer Drug Market will surpass US$ 30.5 Billion by the year end of 2025

Growth in demand for targeted drug therapy, increasing per capita income, rising out of pocket expenditure, people awareness regarding the risk of various cancer, technology advancement are some other factors driving the demand for cancer drugs in China.

Although the negative news is that the mortality rate of cancer patients is growing in China as the cost of a cancer drug is quite high, and there are many side effects of these cancer drugs. Moreover, due to a change in food habits & lifestyle, the aging population, tobacco smoking, the problem is growing.

In terms of mortality, cancer is the second-largest disease in the world. As China is the most populous country in the world, the risk and prevalence rate is increasing at a rapid pace. Per capita income of China are rising since long period of time, people prefer urbanization and western-style food habits. Due to increasing urbanization, the number of smokers rises leads to an increase in the risk of cancer. Being the most significant emerging economies expanding the number of cancer drug products in China will further boost the market in the coming future. Targeted drug therapy is most prevalent in China because of lower side effects.

Request a free Brochure copy of the report: https://www.renub.com/request-sample-page.php?gturl=china-cancer-drugs-market-p.php

China Cancer Drug Market – By Drug Type

In this section of the report, the market is divided into six parts; Monoclonal Antibiotics, Targeted Drugs, Hormonal Drugs, Cytotoxic Drugs,TCM, and Others. The class of cytotoxic drugs is further classified into three parts: antimetabolites, alkaloids of plants, and alkylating agents. Currently, targeted drugs have more ability to kill malignant cells, and they are quite successful due to higher success rates and effectiveness.

Market by Cancer Type

In this study, we have conducted an in-depth market analysis by cancer types; Lung, Stomach, Breast, Esophageal, Liver, & Others. Lung cancer constitutes the largest market share because of the high prevalence rate and the increasing smoker population in China.

Market by Therapy

Targeted drug therapy is growing significantly in China because of its higher effectiveness and success rate than other therapies, according to Renub Research Analysis. In this research, we have assessed a multi-dimensional approach to study each and every cancer therapy that constitutes numerous variables such as core factors supporting market growth, opportunities assessment by each therapy, various challenges that occurred in cancer therapy, etc.

Key Players Analysis

In this section of the report, we have done a complete analysis of top key players. The topmost key players are; Merck, Celgene, Eli Lilly, Roche, and Sino BioPharma. The report includes business overview, historical revenue analysis & forecast, the strategy of the company, and recent development, etc.

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Key Topics Covered :

  1. Introduction
  2. Research Methodology
  3. Executive Summary
  4. China Cancer Drugs Market
  5. Market Share – China Anti-Cancer Drugs

5.1 By Drugs
5.2 By Cancer
5.3 By Therapy

  1. Drugs – China Cancer Market

6.1 Cytotoxic Drugs
6.2 Targeted Drugs
6.3 Monoclonal Antibiotics
6.4 Hormonal Drugs
6.5 Traditional Chinese Medicine (TCM)
6.6 Others

  1. Cancer Type – Market

7.1 Lung Cancer
7.2 Stomach Cancer
7.3 Breast Cancer
7.4 Esophageal Cancer
7.5 Liver Cancer
7.6 Others

  1. Therapy – China Cancer Market

8.1 Chemotherapy
8.2 Targeted Therapy
8.3 Hormonal Therapy
8.4 Others

  1. Company Analysis

9.1 Merck
9.2 Celgene
9.3 Eli Lilly
9.4 Roche
9.5 Sino BioPharma

  1. Growth Drivers

10.1 Growing Awareness towards Cancer Diagnosis and Treatment
10.2 Increasing Use of Targeted Therapy
10.3 Increasing Research and Development Activities
10.4 Cutting Import Duties on Cancer Drugs

  1. Challenges

11.1 High Cost of Cancer Drugs
11.2 Major Side Effects of Cancer Treatment

About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us

Renub Research
Phone: +1-678-302-0700
Email: info@renub.com
Website: www.renub.com
Follow us on LinkedIn: www.linkedin.com/company/renub-research

China Vaccine Market will be USD 9 Billion by 2025 – Renub Research

China Vaccine Market & Doses Forecast By Sector (Private, Public), Disease Type, Products, “Company”

The China Vaccine Market is projected to cross USD 9 Billion mark by the end of the year 2025. The significant factors that are propelling the market growth are; rising awareness among people, growing research, and development expenditure in the vaccine sector, improving healthcare infrastructure in China, rising per capita income.

The China vaccine market is projected to cross USD 9 Billion mark by the end of the year 2025

To promote the broader uses of the vaccines, the Chinese government is facilitating vaccines at low cost or even giving it free in government hospitals. They are also increasing private centers that can promote vaccine services based on customer demand.

The government of China withdraws the one-child policy in the year 2017. Therefore an increasing number of newborn babies reached 16.7 Million in the year 2018, and again this number is expected to grow in the coming future. China is one of the world’s biggest vaccine manufacturers. So, higher demand and proper supply of vaccines will further boost the China vaccine market during the forecast period.

Chinese people are quite aware of immunization, and private companies have invested a massive chunk of money in sustaining the market growth of China Vaccine market in the long run. In the past few years, China’s vaccine market has faced several scandals, which may restrain the growth of the vaccine market.

China Vaccine Market Analysis by Disease Type

In this section of the report, we have done China vaccine market analysis by disease type. Meningococcal meningitis, Pneumococcal, and DTP Vaccine are the first vaccine dominating the overall China vaccine market and anticipated to capture the largest share in the vaccine market. Based on the disease type vaccine market of China is divided into Meningococcal meningitis, Pneumococcal, DTP, Ebola, Rabies & Others.

Request a free Brochure copy of the report: https://www.renub.com/request-sample-page.php?gturl=china-vaccine-market-p.php

China Vaccine Market Analysis by Products

Based on the product, the China vaccine market is fragmented into seven parts; MCV4, MPSV4, MCV2-Hib, MCV2, MPSV2, and Men A, PCV13, and PPV23. PCV13 vaccine product gained the largest market share in the overall market. It is anticipated that PCV13 continues to hold the leading market position during the forecast period.

China Vaccine Market Analysis by Public and Private Vaccine

This section of the report provides a detailed analysis of the Public and Private Vaccine market along with several government initiatives and private expenditure on R&D process.

Company Analysis Covered in the Report

In this section of the report, we have done an overall analysis of leading key players such as business overview, sales analysis, and recent development and strategy of the below mentioned 6 countries.

  1. Sinopharm Group (China National Biotec Group Company Limited)
  2. Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd
  3. Chongqing Zhifei Biological Products Co Ltd
  4. Hualan Biological Engineering Inc
  5. Liaoning Chengda Co Ltd
  6. Walvax Biotechnology Co Ltd

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Key Topics Covered :

  1. Introduction
  2. Research & Methodology
  3. Executive Summary
  4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities

  1. China Vaccine Market

5.1 Public
5.2 Private

  1. China Vaccine Doses

6.1 Public
6.2 Private

  1. Market Share – China Vaccine Analysis

7.1 By Sectors
7.2 By Vaccine Doses Share
7.3 By Products Type
7.4 By Disease Type

  1. Meningococcal Meningitis Vaccine

8.1 Market
8.2 Vaccine Doses
8.3 Vaccine Pipeline

  1. Pneumococcal Vaccines

9.1 Market
9.2 Doses
9.3 Vaccine Pipeline

  1. DTP Vaccine

10.1 Market – DTP Vaccine
10.2 Doses – DTP Vaccine
10.3 Vaccine Pipeline

  1. Rabies Vaccine Market
  2. Ebola Vaccine

12.1 Market
12.2 Vaccine Pipeline

  1. Products Type – China Vaccine Market

13.1 MCV4
13.2 MPSV4
13.3 MCV2-Hib
13.4 MCV2
13.5 MPSV2 and Men A
13.6 PCV13
13.7 PPV23

  1. Vaccine Regulatory Authority of China
  2. Required and Recommended Vaccinations for China Travel
  3. Mergers and Acquisitions
  4. Company Analysis

17.1 Sinopharm Group (China National Biotec Group Company Limited)
17.2 Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd
17.3 Chongqing Zhifei Biological Products Co Ltd
17.4 Hualan Biological Engineering Inc.
17.5 Liaoning Chengda Co. Ltd.
17.6 Walvax Biotechnology Co. Ltd.

About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us

Renub Research
Phone: +1-678-302-0700
Email: info@renub.com
Website: www.renub.com
Follow us on LinkedIn: www.linkedin.com/company/renub-research

Global Meal Kit Market will be US$ 15.5 Billion by 2025 – Renub Research

Meal Kit Market Global Analysis by Country, Ordering Method (Online, Offline), Category (Vegetarian, Non-Vegetarian), Type (Fresh Food, Process Food) & Companies (Blue Apron Holdings, Inc., Goodfood, HelloFresh, Marley Spoon Inc., Home Chef) provides a complete analysis of the global meal kit market.

A meal kit is a subscription based foodservice business in which a food business sends fresh food ingredients and half prepared food ingredients along with recipes to prepare homemade meals to its customers. The global meal kits market is expected to surpass US$ 15 Billion by the end of year 2025.

The major factors that would propel the meal kits market growth are; rising number of professionals, people having less time to cook, it’s very hard to find the exact ingredient for specific recipe, available in fresh & partially prepared ingredients, people love to make food by own, innovative recipe, quality ingredient with nutritional value, the trend of nuclear families are rising across the world, rising per capita income, acceptance of meal kits in major developed countries.

global meal kit marekt – renub.com

The good part of meal kits is to really reduce the wastage of food because companies provide exact quantity of intergradient in the box. Companies are considering many aspects to provide convenience to the customer like food preparation, grocery purchase planning, lunch time menu, dinner time menu, nutritional value age wise etc.

Meal kits are available in online and offline both forms, but online platform is most popular among consumer because of increasing penetration of mobile all across the world. Meal kits businesses are performing well in developed nation like United States and Europe. But companies are also planning to boost the concept in Asian region.

Companies are also customizing their product according to region, age and health specific requirement. Many companies also offer gluten free ingredients and various recipes that are compatible for diabetes patients.

Request a free Brochure copy of the report: https://www.renub.com/request-sample-page.php?gturl=meal-kit-market-p.php

By Regions

In this section, we have done complete assessment of region profile and categorized it into 9 parts; Canada, United States, Germany, United Kingdom, China, Japan, Australia, France, rest of the world. Besides we have also mentioned the various growth factors and key challenges associated with each region.

By Ordering Method

In this section, market is divided into two parts; online and offline. Online platform has the faster growth due to convenience and increasing mobile penetration all across the world. Grocery and supermarket have also developed their strategy to sell meal kits across various locations. One of the major advantage of offline platform is consumer don’t have to subscribe for meal kits, they can just pick from the grocery and supermarket whenever they are required.

By Product

In this section of the report, the market is fragmented into two parts; vegetarian and non-vegetarian. Non-vegetarian market dominates the overall meal kits market but vegetarian segment is growing significantly over a period time.

By Product Type

In this section of the report, the market is categorized into two parts; fresh meal kits and partially cooked meal kits. Currently partially cooked meal kits are dominating the market but fresh meal kits are also performing well in the market.

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Key Topics Covered :

  1. Introduction
  2. Research & Methodology
  3. Global Meal Kit Market
  4. Market Share Analysis – Global Meal Kit

4.1 By Country
4.2 By Category
4.3 By Type
4.4 By Purchasing Methods

  1. Country – Global Meal Kit Market

5.1 United States
5.2 Canada
5.3 Australia
5.4 China
5.5 Japan
5.6 Germany
5.7 France
5.8 United Kingdom
5.9 Others

  1. Category – Global Meal Kit Market

6.1 Vegetarian
6.2 Non-Vegetarian

  1. Type – Global Meal Kit Market

7.1 Fresh Food
7.2 Process Food

  1. Ordering Methods – Global Meal Kit Market

8.1 Offline Meal Kit
8.2 Online Meal Kit

  1. Company Analysis

9.1 Blue Apron Holdings, Inc.
9.2 Goodfood
9.3 HelloFresh
9.4 Marley Spoon Inc.
9.5 Home Chef (Acquired by Kroger Co.)

About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us

Renub Research
Phone: +1-678-302-0700
Email: info@renub.com
Website: www.renub.com
Follow us on LinkedIn: www.linkedin.com/company/renub-research

Japan Hotel Market will be 26.8 Billion by 2025 – Renub Research

Renub Research report titled “Japan Hotel Market, Volume & Forecast by Type (High End, Mid Scale, Budget) Ordering Platform (Online, Offline), Region (Tokyo,Osaka, Kyoto, Nagoya, and Others ), Hotel/Company (APA Hotels and Resorts, Marriot International, Tokyu Hotels, JR Hotel Group)” provides a complete analysis of Japanese Hotel Market.

The hotel industry of Japan is expected to cross US$ 26 Billion mark by the end of year 2025. The core factors that fuel the market growth are; growing demand of demand of hotel room, increasing number of tourists’ arrival in Japan, rise in online hotel booking etc.

 The hotel industry of Japan is expected to cross US$ 26 Billion mark by the end of year 2025.hotel type is categorized into three parts; High End, Mid Scale, and Budget.

As mid-scale segment of hotel has huge demand in Japan, therefore this category of hotel is facing over demand during recent times. The government of Japan is taking major initiatives to improve the supply of hotel as government has set the goal to receive 60 million people by the end of year 2030.

Many big events happen in Japan which also makes it more attractive for foreign tourist as well as domestic tourist. The major past and future event are; Rugby World Cup happened in the year 2019, Olympic will be coming soon in the month of July 2020 in the Tokyo city, Osaka-Kansai World Expo will be happen by the year 2025.

As we know Japan has highest number of working professional, recently Japanese government and other stakeholder reform the working days to 4 days in the week. Therefore people will have more time to spend on vacation. Leisure domestic tourism likely to expand in Japan, this will boost the Japan hotel industry in coming future. The major city that has huge demand of hotels are; Tokyo, Osaka, Kyoto, and Nagoya. The number of hotels stocks is rising in Japan due to several coming mega events and it will continue to be rising in future course of time to accommodate rising tourist demand.

Analysis by Hotel Type

In this report, hotel type is categorized into three parts; High End, Mid Scale, and Budget. The demand of high end and mid-scale are quite high in Japan, although budget hotels are performing well. Besides Japan hotel market by mid-scale hotel dominates the overall market because demand is higher than supply. This report also provides the detailed analysis of star-rated hotels in Japan.

Analysis by Ordering Platform

In this section Japan hotel market is divided into two parts; online and offline. Japanese people are steadily shifting to online platform for booking hotel due to rising internet penetration and smartphone penetration.

Request a free Brochure copy of the report: https://www.renub.com/request-sample-page.php?gturl=japan-hotel-market-p.php

Analysis by Region

This section provides the complete assessment of Japan hotel market by city profile. Here the market is divided into five parts; Tokyo, Osaka, Kyoto, Nagoya and Rest of Japan. This section also provides the multi-factor analysis of regional profile; various growth factors and challenges faced by each region.

Analysis by Company

This report provides complete analysis of leading key players; APA Hotels and Resorts,, Marriot International, Tokyu Hotels and JR Hotel Group. The analysis is done by two perspective; sales analysis and recent development & strategy.

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Key Topics Covered :

  1. Introduction
  2. Research & Methodology
  3. Executive Summary
  4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities

  1. Japan Hotel Market

5.1 Market
5.2 Volume
5.3 ADR (Average Daily Rent Per Night)
5.4 REVPAR (Per Room per Night)
5.5 Occupancy Rate

  1. Market & Volume Share – Japan Hotel Market

6.1 Market Share
6.2 Volume Share

  1. Hotel Type – Japan Hotel Volume & Market

7.1 High End Hotel
7.2 Mid Scale Hotel
7.3 Budget Hotel

  1. Ordering Platform – Japan Hotel Market

8.1 Online Hotel
8.2 Offline Hotel

  1. Region – Japan Hotel Market

9.1 Tokyo
9.2 Osaka
9.3 Kyoto
9.4 Nagoya
9.5 Others

  1. Japan Hotel Ranking By Size – 2017
  2. Japan Payment Method
  3. Japan Inbound Tourism Market

12.1 Foreign Tourist Arrivals
12.2 Domestic Tourist Arrivals

  1. Purpose – Japan Inbound Tourism Market

13.1 Tourism and Leisure
13.2 Business
13.3 Others

  1. Japan Tourism Analysis

14.1 Countries – Number of Visitors Japan in 2018
14.2 Number of International Trips Taken Per Capita by Countries
14.3 Accommodation Bed Occupancy Rates by Prefecture (2016)
14.4 Accommodation Room Occupancy Rates by Prefecture (2016)
14.5 Actual Number of International Overnight Guests, Average Nights per Person (2016)
14.6 Breakdown of International Visitors ‘Travel Expenditure in Japan by Country/Region (2016)

  1. Mergers and Acquisitions
  2. Company Analysis

16.1 APA Hotels and Resorts
16.2 Marriot International
16.3 Tokyu Hotels
16.4 JR Hotel Group

About Us:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us

Renub Research
Phone: +1-678-302-0700
Email: info@renub.com
Website: www.renub.com
Follow us on LinkedIn: www.linkedin.com/company/renub-research